S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
BATS:VIRS

Pacer BioThreat Strategy ETF (VIRS) Price, Holdings, & News

$34.07
-0.28 (-0.82%)
(As of 04/17/2024 ET)
Today's Range
$34.07
$34.07
50-Day Range
$33.71
$36.20
52-Week Range
N/A
Volume
227 shs
Average Volume
N/A
Market Capitalization
$3.41 million
Assets Under Management
$3.43 million
Dividend Yield
0.93%
Net Expense Ratio
0.70%

About Pacer BioThreat Strategy ETF

The Pacer BioThreat Strategy ETF (VIRS) is an exchange-traded fund that is based on the LifeSci BioThreat Strategy index. The fund tracks a market-cap weighted index of US companies whose products or services address biological threats to human health. VIRS was launched on Jun 24, 2020 and is managed by Pacer.

VIRS Stock Price History

VIRS ETF News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive VIRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pacer BioThreat Strategy ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Pacer Financial
Fund Name
Pacer BioThreat Strategy ETF
Tax Classification
Regulated Investment Company
Inception Date
6/24/2020
Fund Manager
Bruce Kavanaugh, Michael Mack
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
LifeSci BioThreat Strategy Index
Category
Strategy
Focus
Theme
Development Level
Developed Markets
Region
North America
Number of Holdings
54

Fund Statistics

Assets Under Management
$3.43 million
Average Daily Volume
$0.00
Discount/Premium
0.02%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Pacer Advisors, Inc.
Custodian
U.S. Bank, N.A.
Distributor
Pacer Financial, Inc.
Transfer Agent
U.S. Bank, N.A.
Trustee
N/A
Lead Market Maker
RBC Capital Markets

Miscellaneous

Beta
0.84
Creation Unit
50,000
Creation Fee
$250.00
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Pacer BioThreat Strategy ETF Expenses

TypeVIRSTheme ETFsEquity ETFsBATS ETFsAll ETFs
Management Fee0.70%0.57%0.54%0.56%0.51%
Other Expenses0.00%0.71%0.54%0.51%0.58%
Total Expense0.70%0.72%0.70%0.68%0.70%
Fee Waiver0.00%-0.76%-0.55%-0.34%-0.57%
Net Expense0.70%0.59%0.60%0.63%0.58%

Pacer BioThreat Strategy ETF (VIRS) Holdings & Exposure

VIRS Sector Exposure

VIRS Industry Exposure


VIRS ETF - Frequently Asked Questions

How have VIRS shares performed in 2024?

Pacer BioThreat Strategy ETF's stock was trading at $32.3154 at the beginning of the year. Since then, VIRS shares have increased by 5.4% and is now trading at $34.0719.
View the best growth stocks for 2024 here
.

How often does Pacer BioThreat Strategy ETF pay dividends? What is the dividend yield for Pacer BioThreat Strategy ETF?

Pacer BioThreat Strategy ETF declared a dividend on Wednesday, September 20th. Shareholders of record on Friday, September 22nd will be paid a dividend of $0.0785 per share on Wednesday, September 27th. The ex-dividend date is Thursday, September 21st.
Read our dividend analysis for VIRS
.

What does VIRS invest in?

Pacer BioThreat Strategy ETF is a equity fund issued by Pacer Financial. VIRS focuses on theme investments and follows the LifeSci BioThreat Strategy Index. The fund's investments total to approximately $3.43 million assets under management.

What stocks does Pacer BioThreat Strategy ETF hold?
What is the management fee for Pacer BioThreat Strategy ETF?

Pacer BioThreat Strategy ETF's management fee is 0.70% and has no other recorded expenses or fee waivers. The net expense ratio for VIRS is 0.70%.

Who are Pacer BioThreat Strategy ETF's major shareholders?

Pacer BioThreat Strategy ETF's stock is owned by a variety of institutional and retail investors. Top institutional investors include International Assets Investment Management LLC (14.36%).

How do I buy shares of Pacer BioThreat Strategy ETF?

Shares of VIRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (BATS:VIRS) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners